Abeona Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Abeona Therapeutics generated cash of -$37,009,000, which is more than the previous year. Cash used in financing activities reached the amount of $37,057,000 last year. Net change in cash is therefore $256,000.
Cash Flow
| 2014 | -1.61M | 0 | 12.70M |
|---|---|---|---|
| 2015 | -10.42M | 3.38M | 35.65M |
| 2016 | -13.01M | -519K | 42.53M |
| 2017 | -22.93M | -860K | 92.40M |
| 2018 | -39.11M | -85.08M | 5.47M |
| 2019 | -62.82M | 59.97M | 113.90M |
| 2020 | -35.01M | -83.71M | 1.93M |
| 2021 | -65.66M | 66.06M | 24.86M |
| 2022 | -43.48M | -23.96M | 43.17M |
| 2023 | -37.00M | 208K | 37.05M |
0H7R.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.55M | 37.92M | 12.59M | 129.25M | 18.75M | 138.03M | 69.14M | 40.13M | 11.52M | 424K |
Operating activities | ||||||||||
Net income | -54.18M | -39.69M | -84.93M | -84.23M | -76.28M | -56.67M | -27.31M | -21.87M | -14.52M | -26.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.19M | 4.57M | 4.46M | 5.60M | 8.67M | 2.36M | 741K | 825K | 551K | 11K |
Stock-based compensation expense | 4.76M | 3.05M | 8.91M | 8.18M | 8.23M | 0 | 5.91M | 8.26M | 9.62M | 1.65M |
| Deferred income tax benefit | 4.76M | 3.05M | 8.91M | 8.18M | 8.23M | 0 | 5.91M | 8.26M | 9.62M | 1.65M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 2.81M | -3M | 0 | 81K | 26K | 17K | -9K | -79K | 39K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.04M | -5.49M | 825K | -2.17M | -1.70M | 0 | -1.30M | 0 | -1.17M | 0 |
Cash generated by operating activities | -37.00M | -43.48M | -65.66M | -35.01M | -62.82M | -39.11M | -22.93M | -13.01M | -10.42M | -1.61M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -78.21M | -20.16M | -170.47M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -331K | -130K | -4.15M | -1.33M | -6.50M | -9.24M | -860K | -519K | -308K | 0 |
Acquisitions Net | 204K | 1.73M | -70.21M | 82.37M | 0 | 0 | 0 | 0 | 3.69M | 0 |
Cash generated by investing activities | 208K | -23.96M | 66.06M | -83.71M | 59.97M | -85.08M | -860K | -519K | 3.38M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 37.20M | 43.17M | 24.86M | 178K | 113.90M | 0 | 92.40M | 0 | 36.05M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -182K | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.75M | 0 | 0 | 0 | 0 | -400K | 0 |
Cash used in financing activities | 37.05M | 43.17M | 24.86M | 1.93M | 113.90M | 5.47M | 92.40M | 42.53M | 35.65M | 12.70M |
Net Change In Cash | 256K | -23.37M | 25.33M | -116.66M | 110.50M | -118.72M | 68.60M | 29.00M | 28.61M | 11.09M |
Cash at end of period | 14.81M | 14.55M | 37.92M | 12.59M | 129.25M | 19.31M | 137.75M | 69.14M | 40.13M | 11.52M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |